Total Payments
$10,962
2023 Payments
$1,164
Companies
41
Transactions
679
Medicare Patients
1,376
Medicare Billing
$153,560
Payment Breakdown by Category
Food & Beverage$10,907 (99.5%)
Education$55.32 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,907 | 672 | 99.5% |
| Education | $55.32 | 7 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,176 | 136 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,110 | 56 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $1,003 | 74 | $0 (2019) |
| Lilly USA, LLC | $1,001 | 69 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $886.90 | 51 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $882.08 | 63 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $846.34 | 49 | $0 (2023) |
| Amgen Inc. | $791.36 | 52 | $0 (2023) |
| PFIZER INC. | $407.70 | 23 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $254.19 | 16 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,164 | 53 | GlaxoSmithKline, LLC. ($383.51) |
| 2022 | $1,401 | 85 | Novo Nordisk Inc ($370.92) |
| 2021 | $1,609 | 106 | Novo Nordisk Inc ($324.12) |
| 2020 | $1,436 | 97 | Novo Nordisk Inc ($317.91) |
| 2019 | $1,870 | 118 | Novo Nordisk Inc ($374.23) |
| 2018 | $1,993 | 121 | Janssen Pharmaceuticals, Inc ($487.01) |
| 2017 | $1,488 | 99 | Merck Sharp & Dohme Corporation ($256.99) |
All Payment Transactions
679 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $108.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/05/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $57.75 | General |
| 12/05/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $4.55 | General |
| 07/14/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: RESPIRATORY | ||||||
| 07/11/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX, AREXVY | Food and Beverage | In-kind items and services | $10.46 | General |
| Category: RESPIRATORY | ||||||
| 05/28/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Diabetes Care | ||||||
| 05/25/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Diabetes | ||||||
| 05/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Diabetes | ||||||
| 05/11/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: DIABETES | ||||||
| 05/10/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: Neuroscience | ||||||
| 05/09/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Diabetes | ||||||
| 05/04/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: RESPIRATORY | ||||||
| 05/03/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Obesity | ||||||
| 05/02/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: INSOMNIA | ||||||
| 04/27/2023 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $19.69 | General |
| Category: Medical Device | ||||||
| 04/25/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: Diabetes | ||||||
| 04/21/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Diabetes | ||||||
| 04/20/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Inflammation | ||||||
| 04/19/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Diabetes | ||||||
| 04/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/12/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.10 | General |
| 04/12/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Neuroscience | ||||||
| 04/06/2023 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Neuroscience | ||||||
| 04/03/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: Diabetes | ||||||
| 03/28/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 422 | 565 | $103,075 | $44,976 |
| 2022 | 5 | 297 | 472 | $72,450 | $34,658 |
| 2021 | 4 | 295 | 523 | $71,450 | $35,485 |
| 2020 | 5 | 362 | 658 | $91,550 | $38,441 |
Total Patients
1,376
Total Services
2,218
Medicare Billing
$153,560
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 161 | $31,700 | $13,450 | 42.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 77 | 77 | $17,180 | $9,483 | 55.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 33 | 33 | $18,440 | $9,052 | 49.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 80 | 155 | $21,640 | $7,452 | 34.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 20 | 20 | $3,000 | $1,439 | 48.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 35 | 38 | $3,700 | $1,253 | 33.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,275 | $1,076 | 32.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 32 | 32 | $1,725 | $942.40 | 54.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 24 | $1,370 | $706.80 | 51.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 14 | 14 | $1,045 | $121.94 | 11.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 107 | 243 | $31,590 | $12,851 | 40.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 83 | 118 | $18,880 | $9,789 | 51.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 70 | 70 | $16,280 | $9,017 | 55.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 11 | 11 | $2,700 | $1,826 | 67.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 26 | 30 | $3,000 | $1,175 | 39.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 115 | 239 | $31,070 | $12,653 | 40.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 89 | 145 | $23,200 | $11,670 | 50.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 80 | 80 | $16,000 | $10,507 | 65.7% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2021 | 11 | 59 | $1,180 | $655.32 | 55.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 126 | 223 | $35,680 | $15,173 | 42.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 136 | 299 | $38,870 | $13,838 | 35.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 74 | 74 | $14,800 | $8,471 | 57.2% |
| 80305 | Testing for presence of drug | Office | 2020 | 15 | 50 | $1,000 | $628.75 | 62.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 11 | 12 | $1,200 | $330.72 | 27.6% |
About Dr. Sulagna De, M.D
Dr. Sulagna De, M.D is a Internal Medicine healthcare provider based in Stroudsburg, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1568515161.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sulagna De, M.D has received a total of $10,962 in payments from pharmaceutical and medical device companies, with $1,164 received in 2023. These payments were reported across 679 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($10,907).
As a Medicare-enrolled provider, De has provided services to 1,376 Medicare beneficiaries, totaling 2,218 services with total Medicare billing of $153,560. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Stroudsburg, PA
- Active Since 01/19/2007
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1568515161
Products in Payments
- Ozempic (Drug) $879.46
- JARDIANCE (Drug) $691.00
- TRELEGY ELLIPTA (Drug) $542.30
- XARELTO (Drug) $541.55
- JANUVIA (Drug) $494.08
- INVOKANA (Drug) $461.54
- EMGALITY (Drug) $399.63
- FARXIGA (Drug) $393.90
- TRADJENTA (Drug) $329.88
- Aimovig (Biological) $323.92
- Saxenda (Drug) $320.18
- TRULICITY (Drug) $307.51
- Prolia (Biological) $284.43
- NURTEC ODT (Drug) $282.12
- Victoza (Drug) $260.44
- Rybelsus (Drug) $251.27
- ELIQUIS (Drug) $233.84
- SYMBICORT (Drug) $204.32
- BELSOMRA (Drug) $199.29
- Tresiba (Drug) $165.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Stroudsburg
Robert Wallen, M.d, M.D
Internal Medicine — Payments: $1,485
Internal Medicine $1,485
Umesh Dalal, M.d, M.D
Internal Medicine — Payments: $1,098
Internal Medicine $1,098
Haseeba Shahzad, M.d, M.D
Internal Medicine — Payments: $739.60
Internal Medicine $739.60
Melissa Zegar, D.o, D.O
Internal Medicine — Payments: $623.19
Internal Medicine $623.19
Leah Stahler, Pa-C, PA-C
Internal Medicine — Payments: $401.77
Internal Medicine $401.77
Dr. Anish Parameswaran, Do, DO
Internal Medicine — Payments: $177.48
Internal Medicine $177.48